The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology
Open accessAbstract
BACKGROUND: Recent discussions have focused on redefining noninvasive follicular variant of papillary thyroid carcinoma (NI‐FVPTC) as a neoplasm rather than a carcinoma. This study assesses the potential impact of such a reclassification on the implied risk of malignancy (ROM) for the diagnostic categories of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC). METHODS: The study consisted of consecutive fine‐needle aspiration biopsy (FNAB) cases collected between January 1, 2013 and June 30, 2014 from 5 academic institutions. Demographic information, cytology diagnoses, and surgical pathology follow‐up were recorded. The ROM was calculated with and without NI‐FVPTC and was presented as a range: all cases (ie, overall risk of malignancy [OROM]) versus those with surgical follow‐up only. RESULTS: The FNAB cohort consisted of 6943 thyroid nodules representing 5179 women and 1409 men with an average age of 54 years (range, 9‐94 years). The combined average ROM and OROM for the diagnostic categories of TBSRTC were as follows: nondiagnostic, 4.4% to 25.3%; benign, 0.9% to 9.3%; atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS), 12.1% to 31.2%; follicular neoplasm (FN), 21.8% to 33.2%; suspicious for malignancy (SM), 62.1% to 82.6%; and malignant, 75.9% to 99.1%. The impact of reclassifying NI‐FVPTC on the ROM and OROM was most pronounced and statistically significant in the 3 indeterminate categories: the AUS/FLUS category had a decrease of 5.2% to 13.6%, the FN category had a decrease of 9.9% to 15.1%, and the SM category had a decrease of 17.6% to 23.4% (P < .05), whereas the benign and malignant categories had decreases of 0.3% to 3.5% and 2.5% to 3.3%, respectfully. The trend of the effect on the ROM and OROM was similar for all 5 institutions. CONCLUSIONS: The results from this multi‐institutional cohort indicate that the reclassification of NI‐FVPTC will have a significant impact on the ROM for the 3 indeterminate categories of TBSRTC. Cancer Cytopathol 2016;124:181–187. © 2015 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Pacini, F., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0110 · Cited by 6,707
The Bethesda System for Reporting Thyroid Cytopathology
Cibas, E. S., & Ali, S. Z. (2009) · Thyroid · doi:10.1089/thy.2009.0274 · Cited by 1,261
Self-citationPreoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
Alexander, E. K., Kennedy, G. C., Baloch, Z. W., Cibas, E. S., Chudova, D., Diggans, J., Friedman, L., Kloos, R. T., LiVolsi, V. A., Mandel, S. J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203208 · Cited by 1,163
Self-citationThe Bethesda System for Reporting Thyroid Cytopathology: A Meta-Analysis
Bongiovanni, M., Spitale, A., Faquin, W. C., Mazzucchelli, L., & Baloch, Z. W. (2012) · Acta Cytologica · doi:10.1159/000339959 · Cited by 1,032
Self-citationHay, I. D., Thompson, G. B., Grant, C. S., Bergstralh, E. J., Dvorak, C. E., Gorman, C. A., Maurer, M. S., McIver, B., Mullan, B. P., Oberg, A. L., et al. (2002) · World Journal of Surgery · doi:10.1007/s00268-002-6612-1 · Cited by 736
Nikiforov, Y. E., Carty, S. E., Chiosea, S. I., Coyne, C., Duvvuri, U., Ferris, R. L., Gooding, W. E., Hodak, S. P., LeBeau, S. O., Ohori, N. P., et al. (2014) · Cancer · doi:10.1002/cncr.29038 · Cited by 500
Baloch, Z. W., Cibas, E. S., Clark, D. P., Layfield, L. J., Ljung, B.-M., Pitman, M. B., & Abati, A. (2008) · CytoJournal · doi:10.1186/1742-6413-5-6 · Cited by 382
Self-citationVaccarella, S., Dal Maso, L., Laversanne, M., Bray, F., Plummer, M., & Franceschi, S. (2015) · Thyroid · doi:10.1089/thy.2015.0116 · Cited by 363
Observer Variation of Encapsulated Follicular Lesions of the Thyroid Gland
Hirokawa, M., Carney, J. A., Goellner, J. R., DeLellis, R. A., Heffess, C. S., Katoh, R., Tsujimoto, M., & Kakudo, K. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200211000-00014 · Cited by 347
Davies, L., Morris, L. G. T., Haymart, M., Chen, A. Y., Goldenberg, D., Morris, J., Ogilvie, J. B., Terris, D. J., Netterville, J., Wong, R. J., et al. (2015) · Endocrine Practice · doi:10.4158/ep14466.dscr · Cited by 327
Molecular Diagnostics of Thyroid Tumors
Nikiforov, Y. E. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2010-0664-rair.1 · Cited by 257
Strickland, K. C., Howitt, B. E., Marqusee, E., Alexander, E. K., Cibas, E. S., Krane, J. F., & Barletta, J. A. (2015) · Thyroid · doi:10.1089/thy.2014.0612 · Cited by 248
Duick, D. S., Klopper, J. P., Diggans, J., Friedman, L., Kennedy, G. C., Lanman, R. B., & McIver, B. (2012) · Thyroid · doi:10.1089/thy.2012.0180 · Cited by 148
Piana, S., Frasoldati, A., Felice, E. D., Gardini, G., Tallini, G., & Rosaí, J. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181dbee07 · Cited by 141
Ghossein, R. A., Hiltzik, D. H., Carlson, D. L., Patel, S. G., Shaha, A. R., Shah, J. P., Tuttle, R. M., & Singh, B. (2006) · Cancer · doi:10.1002/cncr.21825 · Cited by 132
Thyroid Cytopathology: Bethesda and Beyond
Ali, S. Z. (2010) · Acta Cytologica · doi:10.1159/000322365 · Cited by 127
Self-citationGupta, S., Ajise, O., Dultz, L. A., Wang, B., Nonaka, D., Ogilvie, J. B., Heller, K. S., & Patel, K. N. (2012) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archoto.2011.1466 · Cited by 104
New Strategies in Diagnosing Cancer in Thyroid Nodules: Impact of Molecular Markers
Nikiforov, Y. E., Yip, L., & Nikiforova, M. N. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1253 · Cited by 92
BRAF mutation detection in indeterminate thyroid cytology specimens
Ohori, N. P., Singhal, R., Nikiforova, M. N., Yip, L., Schoedel, K. E., Coyne, C., McCoy, K. L., LeBeau, S. O., Hodak, S. P., Carty, S. E., et al. (2012) · Cancer Cytopathology · doi:10.1002/cncy.21229 · Cited by 74
Baloch, Z. W., Shafique, K., Flanagan, M. B., & LiVolsi, V. A. (2010) · Endocrine Practice · doi:10.4158/ep10060.or · Cited by 71
Self-citationEncapsulated follicular variant of papillary thyroid carcinoma.
Jl, H., Đačić, S., Barnes, E. L., & Jc, B. (2002) · PubMed · Cited by 19
Cited by
Ultrasound Elastography: Review of Techniques and Clinical Applications
Sigrist, R. M. S., Liau, J., Kaffas, A. E., Chammas, M. C., & Willmann, J. K. (2017) · Theranostics · doi:10.7150/thno.18650 · Cited by 1,877
The 2017 Bethesda System for Reporting Thyroid Cytopathology
Cibas, E. S., & Ali, S. Z. (2017) · Thyroid · doi:10.1089/thy.2017.0500 · Cited by 1,844
Self-citationPatel, K. N., Yip, L., Lubitz, C. C., Grubbs, E. G., Miller, B. S., Shen, W., Angelos, P., Chen, H., Doherty, G. M., Fahey, T. J., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003580 · Cited by 541
Haugen, B. R., Sawka, A. M., Alexander, E. K., Bible, K. C., Caturegli, P., Doherty, G. M., Mandel, S. J., Morris, J. C., Nassar, A., Pacini, F., et al. (2017) · Thyroid · doi:10.1089/thy.2016.0628 · Cited by 339
The 2017 Bethesda System for Reporting Thyroid Cytopathology
Cibas, E. S., & Ali, S. Z. (2017) · Journal of the American Society of Cytopathology · doi:10.1016/j.jasc.2017.09.002 · Cited by 315
Self-citation
Metadata
- Authors
- Faquin, W. C., Wong, L. Q., Afrogheh, A. H., Ali, S. Z., Bishop, J. A., Bongiovanni, M., Pusztaszeri, M. P., VandenBussche, C. J., Gourmaud, J., Vaickus, L. J., & Baloch, Z. W.
- Venue
- Cancer Cytopathology
- Publisher
- Wiley
- Published
- 2015-10-12
- Volume
- 124
- Issue
- 3
- Pages
- 181-187
- ISSN
- 1934-662X (ISSN-L)
- 1934-6638
- OpenAlex
- W1930854244
- Cited by
- 311
- References
- 21
- FWCI
- 34.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.